Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 15, 2026
TickeronGET DAILY SIGNALS
Ryan Specialty Holdings (RYAN): Analyzing the Path to +15% Upside Toward $54

Ryan Specialty Holdings (RYAN): Analyzing the Path to +15% Upside Toward $54

Key Takeaways

  • The $54 central target represents the arithmetic mean of eight analyst price targets above the latest market price, not an official Street consensus.
  • With shares near $46.89, reaching $54 would require roughly 15% upside, a substantial move from current levels.
  • The full analyst range is unusually wide, from about $40 to $67, while the overall mean of all tracked targets sits closer to $49.
  • Third-quarter 2026 revenue rose 4.7% to $790 million and adjusted EPS grew 8.5%, but organic growth slowed to 4% from 15% a year earlier.
  • The strongest supports are durable excess-and-surplus (E&S) market flow, buybacks, and new AI-related risk products; the biggest risks are softening property pricing and broadening casualty competition.

Understanding the Analyst Targets

Ryan Specialty Holdings, Inc. (RYAN) is a specialty insurance services firm that acts as a wholesale broker and managing underwriter for insurance brokers, agents, and carriers. Its analyst coverage is broad but sharply divided, which is why the target used here requires explanation.

The overall average of all tracked 12-month targets is roughly $49, only about 4% above the current price, so it fails the minimum-distance test used for this analysis. The $54 figure is instead the mean of the eight valid targets that sit above the current price: BofA at $67, TD Cowen at $62, Citi at $53.50, UBS and RBC Capital at $52, Morgan Stanley at $50, Keefe Bruyette at $49, and Mizuho at $48. That is a rounded average of about $54.

Below that cluster sit Piper Sandler at $40, JPMorgan at $44 (with an Underweight stance), and Wells Fargo at $46. The spread from $40 to $67 reflects genuine disagreement: bullish analysts cite Ryan's structural share gains in specialty distribution, while more cautious analysts focus on the decelerating organic growth rate and a softening property-and-casualty pricing cycle. None of these targets is a guarantee of future performance. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Where the Stock Stands Today

The latest verified close is about $46.89, within a 52-week range of $29.28 to $58.91. A move to $54 would represent roughly 15% upside, which is a substantial advance requiring both multiple support and continued earnings delivery. The stock trades at a premium trailing P/E ratio near 59, so the path toward $54 depends less on re-rating and more on sustained adjusted-earnings growth and stabilizing organic revenue.

Third-quarter 2026 results showed revenue of $790 million (up 4.7%), adjusted EBITDAC of $244.4 million, and adjusted diluted EPS of $0.51, up 8.5%. Management reaffirmed guidance for organic revenue growth toward the higher end of its mid-single-digit range for 2026 while modestly improving its margin outlook.

Drivers That Could Push Toward $54

  • Continued flow of business into the E&S market, where Ryan holds a leading wholesale position, supports structurally higher growth than the broader insurance industry.
  • Aggressive capital returns: the company repurchased $150 million of stock in the third quarter and about $500 million year-to-date, roughly 5% of shares outstanding.
  • Innovation in emerging risks, including a new underwriting facility offering up to $625 million of capacity for AI-related GPU exposure.
  • Improving profitability, with adjusted EPS up 15.1% through the first nine months of 2026, and a management expectation of modest margin expansion in most years.
  • Potential M&A acceleration in 2027, which management views as a likely driver of additional distribution capacity.

Potential Headwinds

  • Organic growth decelerated to 4% in Q3 2026 from 15% in the prior-year quarter, and property pricing is expected to keep declining into 2027.
  • Casualty competition has broadened into higher-hazard classes, and binding-authority specialty faces pressure from new facilities and admitted-market rivals.
  • Margin absorption from late-2025 talent investments and higher benefits costs weighed on adjusted EBITDAC margin, which slipped to 30.9%.
  • A premium valuation near 59x trailing earnings leaves little room for disappointment if growth or margins miss expectations.
  • Higher interest expense on roughly $3.7 billion of debt principal and a tougher Q1 2027 comparison from the Markel Re acquisition add near-term uncertainty.

Technical Picture

The 52-week high of $58.91 and low of $29.28 frame a wide, volatile range. On the way to $54, the stock faces an initial resistance zone around $48 to $50, where several analyst targets and the psychologically important $50 level cluster, followed by the $53 to $55 area. The 52-week high near $59 represents the next major ceiling above the target. On the downside, support sits near $44 to $46, with a firmer floor around the $40 level.

What to Watch Going Forward

Analyst price targets generally reflect a research horizon of about 12 months, though individual firms apply different assumptions. Investors should watch the fourth-quarter 2026 earnings report, organic revenue growth trends, property pricing conditions, casualty competition, margin trajectory, the pace of buybacks, and any analyst target revisions. Interest-rate decisions and macroeconomic conditions also influence the property-and-casualty cycle.

Leveraging Tickeron’s AI Daily Buy/Sell Signals

In my own research, I regularly review Tickeron’s AI Daily Buy/Sell Signals to monitor how market conditions and technical factors are shifting for holdings like this one. The system scans thousands of stocks and ETFs to generate Buy, Sell, or Hold signals based on AI-driven analysis, which helps me stay on top of trends without relying solely on manual checks. It serves as a useful complement when evaluating names with wide analyst ranges and evolving fundamentals.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: RYAN

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


RYAN sees MACD Histogram just turned negative

RYAN saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 42 instances where the indicator turned negative. In 33 of the 42 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for RYAN moved out of overbought territory on November 09, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 similar instances where the indicator moved out of overbought territory. In 23 of the 34 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 44 of 61 cases where RYAN's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 72%.

The Momentum Indicator moved below the 0 level on November 19, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RYAN as a result. In 59 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 70%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RYAN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 69%.

RYAN broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

RYAN moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RYAN crossed bullishly above the 50-day moving average on October 23, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 8 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.

Following a +3.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where RYAN advanced for three days, in 200 of 317 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.

The Aroon Indicator entered an Uptrend today. In 141 of 249 cases where RYAN Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 57%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 38 (best 1 - 100 worst), indicating steady price growth. RYAN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 80 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RYAN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock better than average.

The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 93 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: RYAN's P/B Ratio (11.438) is slightly higher than the industry average of (2.794). RYAN has a moderately high P/E Ratio (61.192) as compared to the industry average of (19.877). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (8.322). Dividend Yield (0.011) settles around the average of (0.042) among similar stocks. P/S Ratio (1.707) is also within normal values, averaging (3.106).

Notable companies

The most notable companies in this group are eHealth (NASDAQ:EHTH).

Industry description

Insurance brokers sell, solicit, or negotiate insurance for compensation. General insurance brokers mostly cater to insurances on car, house etc. (versus life). Brokers are also often instrumental in helping small employers find health insurance, particularly in more competitive markets. Additionally, brokers may also provide risk assessments, insurance consulting services, insurance-related regulatory and legislative update services. Some of the major names in this industry include Marsh & McLennan Companies, Inc., Aon plc and Verisk Analytics Inc.

Market Cap

The average market capitalization across the Insurance Brokers/Services Industry is 16B. The market cap for tickers in the group ranges from 3.03K to 97.74B. MRSH holds the highest valuation in this group at 97.74B. The lowest valued company is CUII at 3.03K.

High and low price notable news

The average weekly price growth across all stocks in the Insurance Brokers/Services Industry was -8%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 17%. HUIZ experienced the highest price growth at 6%, while SLQT experienced the biggest fall at -45%.

Volume

The average weekly volume growth across all stocks in the Insurance Brokers/Services Industry was 29%. For the same stocks of the Industry, the average monthly volume growth was -34% and the average quarterly volume growth was -18%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 59
P/E Growth Rating: 74
Price Growth Rating: 50
SMR Rating: 70
Profit Risk Rating: 85
Seasonality Score: 9 (-100 ... +100)
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry InsuranceBrokersServices

Industry
N/A
Address
155 North Wacker Drive
Phone
+1 312 784-6001
Employees
6110
Web
https://www.ryanspecialty.com
Interact to see
Advertisement
SDD is an inverse leveraged ETF (exchange-traded fund) built to return roughly -2x the daily move of the S&P SmallCap 600 Index, making it a tactical hedging tool rather than a long-term holding. XXX is an asset-allocation ETF that blends roughly 75% S&P 500 large-cap equities with a 25% sleeve of XRP, a major cryptocurrency, aiming for capital appreciation.
AMD jumped +2.42%, rising $12.81 to $542.95 from Wednesday's close of $530.14, in early regular-session trading Thursday after extending gains built during premarket. The catalyst was Anthropic's IPO, priced at $83 a share above its marketed range and raising $81.3 billion in the largest listing on record; the debut revived sentiment across AI hardware names, and AMD is both an Anthropic supplier and a $2.5 billion investor in the lab.
ROM is an established, leveraged exchange-traded fund (ETF) that targets twice (2x) the daily return of the S&P Technology Select Sector Index, while XXX is a recently launched blended ETF pairing large-cap U.S. equities with XRP exposure. ROM benefits from deep liquidity and roughly $1.1 billion in AUM (assets under management); XXX remains far smaller, with assets measured in the hundreds of thousands of dollars.
NVIDIA (NVDA) has declined roughly 32.6% over the last 30 days, falling from $216.47 on October 20 to around $146 in mid-November trading. The selloff was triggered by the surprise resignation of founder and CEO Jensen Huang, along with governance, regulatory, and China-related concerns.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Ryan Specialty Holdings (RYAN): Analyzing the Path to +15% Upside Toward $54